戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 , and this effect was blocked by a selective H2 receptor antagonist.
2 samples from the patients who were receiving H2 receptor antagonists.
3 nges, which were blocked by histamine H1 and H2 receptor antagonists.
4 ations suggest an immune-enhancing effect of H2-receptor antagonists.
5 5-HT1B receptor agonist and histamine H1 and H2 receptor antagonist activities.
6                          Roxatidine, a novel H2 receptor antagonist, acts through a mechanism that in
7                              Although use of H2-receptor antagonists (adjusted OR, 1.84; 95% CI, 1.71
8                Antithrombotics, antibiotics, H2 receptor antagonists, and corticosteroids were often
9 illed, facilitated electronic prescribing of H2 receptor antagonists, and education for patients and
10 as lower charges than initial endoscopy when H2-receptor antagonists are used to prevent recurrence o
11         All patients received a histamine-2 (H2)-receptor antagonist-blocking agent during the study.
12 histamine were antagonized by cimetidine, an H2 receptor antagonist, but not by selective H1 and H3 r
13 s from those patients who were not receiving H2 receptor antagonists, but did not change significantl
14                                          The H2 receptor antagonist cimetidine (2 microM) blocked the
15                                  Neither the H2 receptor antagonist cimetidine (20 microM) nor the H3
16 ptor antagonist diphenhydramine, whereas the H2 receptor antagonist cimetidine had no effect.
17                               Vehicle or the H2 receptor antagonist cimetidine has no effect.
18 t was prevented by treatment with either the H2 receptor antagonist cimetidine or with the potassium
19                                       As the H2 receptor antagonist cimetidine was perfused to the ti
20 F92374, a structural analog of the histamine H2 receptor antagonist cimetidine, induces antinocicepti
21 an H1 receptor antagonist (pyrilamine) or an H2 receptor antagonist (cimetidine) demonstrated a prote
22 f PPI (n=173,321) and new users of histamine H2-receptor antagonists (H2 blockers; n=20,270) and foll
23 optosis in pre-clinical models and histamine H2 receptor antagonist (H2RA) use may improve symptoms i
24 al indications, we examined associations for H2 receptor antagonists (H2RAs) as a secondary aim.
25 e combination of CCK2/gastrin- and histamine H2-receptor antagonists has synergistic inhibitory effec
26                                The histamine H2-receptor antagonists have been identified as inhibito
27  to evaluate whether cimetidine, a histamine H2-receptor antagonist, interferes with the initiation a
28 mys were orally administered an irreversible H2-receptor antagonist loxtidine for 0, 8, and 16 weeks,
29 ceptor antagonist YF476 and/or the histamine H2-receptor antagonist loxtidine for 3 or 6 months.
30 he quad does not have drug interactions with H2-receptor antagonists or proton pump inhibitors, does
31 ntage of patients who filled either a PPI or H2 receptor antagonist prescription, hospital admission
32 % to -5.36%) in patients who filled a PPI or H2 receptor antagonist prescription.
33 tor antagonist chlorpheniramine, but not the H2 receptor antagonist ranitidine, blocks the effects of
34 evere thrombocytopenia after exposure to the H2 receptor antagonist, ranitidine, and identified an an
35 ore, SQ29548, a thromboxane A2/prostaglandin H2 receptor antagonist, significantly reduced CD40L-enha
36 sociated with cimetidine and other histamine H2-receptor antagonists, splenectomy, gonorrhea, and bod
37 ever, neither a thromboxane A2/prostaglandin H2 receptor antagonist SQ29548 and a thromboxane synthas
38                           Examination of the H2-receptor antagonist structures for insight into the m
39                                       In the H2 receptor antagonist studies, CVC in control sites was
40                     Cimetidine is a powerful H2 receptor antagonist that eliminates histamine's effec
41                          As cimetidine is an H2 receptor antagonist, the authors hypothesize that thi
42 rpose of this study was to determine whether H2-receptor antagonist use affects the overall incidence
43 licylate + metronidazole + tetracycline + an H2-receptor antagonist, was supported by two pivotal lit
44 stopped at least 7 days before the study and H2 receptor antagonists were stopped for at least 24 hou